Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma (Q33410213)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma |
scientific article |
Statements
1 reference
Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma (English)
1 reference
Ruben Niesvizky
1 reference
Robert Z Orlowski
1 reference
Michael Wang
1 reference
Tom Martin
1 reference
William Bensinger
1 reference
Melissa Alsina
1 reference
David S Siegel
1 reference
Edward Kavalerchik
1 reference
Mei Huang
1 reference
6 September 2013
1 reference
Identifiers
1 reference